2023 All-Russian screening for hypertension: results
O. P. Rotar,
I. N. Ilyanova,
M. A. Boyarinova,
E. V. Moguchaya,
K. M. Tolkunova,
V. A. Dyachkov,
O. A. Rubanenko,
A. O. Rubanenko,
O. E. Gaberman,
E. Yu. Gubareva,
B. V. Pomogaibo,
E. M. Dolya,
V. B. Kaliberdenko,
I. V. Avdeeva,
Yu. A. Tomashevskaya,
A. Yu. Falkovskaya,
M. A. Manukyan,
E. I. Solonskaya,
A. A. Vtorushina,
S. A. Khunkhinova,
V. M. Tsareva,
L. E. Molokoedova,
M. M. Petrova,
D. S. Kaskaeva,
I. V. Romanova,
L. K. Danilova,
A. A. Evsyukov,
O. V. Tutyrina,
L. E. Tepnadze,
T. I. Yakunchenko,
O. V. Mevsha,
Yu. A. Sharapova,
T. M. Chernykh,
E. V. Syomkina,
O. V. Tsygankova,
K. V. Protasov,
O. V. Fedorishina,
E. R. Makeeva,
Y. A. Smolkina,
D. D. Nikishina,
A. S. Verushkina,
E. A. Smirnova,
Ya. A. Belenikina,
I. V. Bikushova,
M. V. Derevyanchenko,
V. V. Fedotov,
M. Yu. Shaposhnikova,
D. V. Sereda,
E. A. Kartashova,
E. I. Zheleznyak,
D. M Rakhmatullina,
L. S. Kiseleva,
M. Evsevieva,
O. V. Sergeeva,
V. D. Kudryavtseva,
A. M. Zavyalova,
V. I. Slezova,
K. T. Kitalaeva,
N. N. Artemov,
A. A. Tanicheva,
A. A. Konradi,
E. V. Shlyakhto https://doi.org/10.15829/1560-4071-2024-5931
EDN: EMCJRB
Abstract
Aim. To assess awareness of blood pressure (BP) level, adherence to therapy and achievement of target BP in residents of Russian regions as part of the 2023 hypertension (HTN) screening campaign.
Material and methods. During May 2023, 4613 participants from 23 cities of Russia took part in the screening. Participation was voluntary without restrictions on sex. All patients aged over 18 years. During screening, BP and pulse were measured three times using automatic or mechanical BP monitors, and a questionnaire about behavioral risk factors, concomitant diseases and therapy was filled out. HTN was diagnosed with systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg and/or taking antihypertensive therapy (AHT).
Results. The analysis included data from 4585 respondents aged 18 to 95 years with an average age of 45 [28;59] years, of which 1729 were men (37,7%). The proportion of hypertensive patients was 49,6%. Among them, 62,8% took AHT and achieved target BP in 76,6% and 45,7% with the target BP criterion <140/90 mm Hg and <130/80 mm Hg, respectively. Most patients took dual AHT (37,4%), while monotherapy and triple therapy was registered in 27,5% and 23,4%, respectively. Initiation of therapy was performed with combination AHT in 43,7% of patients with HTN and 41,4% are currently using fixed-dose combination therapy. On-demand therapy was the most common reason for skipping medications and was more common in women, while men more often cited the high drug cost and a history of adverse reactions. Among patients with HTN, home BP measurement was associated with a higher prevalence of achieving target BP as follows: 1000 (60%) vs 100 (17%), p<0,001.
Conclusion. The data obtained indicate, on the one hand, a continuing insufficient level of awareness about high BP and the use of antihypertensive drugs among the population, but there is a tendency to improve the effectiveness of the treatment of hypertension, including the use of fixed-dose combinations of antihypertensive drugs.
Supporting agencies: This article was prepared with the support of Servier.
About the Authors
O. P. Rotar
Almazov National Medical Research Center
Russian Federation
Russian Federation
St. Petersburg
I. N. Ilyanova
Almazov National Medical Research Center
Russian Federation
Russian Federation
St. Petersburg
M. A. Boyarinova
Almazov National Medical Research Center
Russian Federation
Russian Federation
St. Petersburg
E. V. Moguchaya
Almazov National Medical Research Center
Russian Federation
Russian Federation
St. Petersburg
K. M. Tolkunova
Almazov National Medical Research Center
Russian Federation
Russian Federation
St. Petersburg
V. A. Dyachkov
Samara State Medical University
Russian Federation
Russian Federation
Samara
O. A. Rubanenko
Samara State Medical University
Russian Federation
Russian Federation
Samara
A. O. Rubanenko
Samara State Medical University
Russian Federation
Russian Federation
Samara
O. E. Gaberman
Samara State Medical University
Russian Federation
Russian Federation
Samara
E. Yu. Gubareva
Samara State Medical University
Russian Federation
Russian Federation
Samara
B. V. Pomogaibo
Mandryk Central Military Clinical Hospital
Russian Federation
Russian Federation
Moscow
E. M. Dolya
S. I. Georgievsky Medical Academy, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Simferopol
V. B. Kaliberdenko
S. I. Georgievsky Medical Academy, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Simferopol
I. V. Avdeeva
Penza State University
Russian Federation
Russian Federation
Penza
Yu. A. Tomashevskaya
Penza State University
Russian Federation
Russian Federation
Penza
A. Yu. Falkovskaya
Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
M. A. Manukyan
Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
E. I. Solonskaya
Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
A. A. Vtorushina
Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
S. A. Khunkhinova
Tomsk National Research Medical Center
Tomsk
V. M. Tsareva
Smolensk State Medical University
Smolensk
L. E. Molokoedova
Pavlovskaya Central District Hospital
Russian Federation
Russian Federation
Pavlovo
M. M. Petrova
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
D. S. Kaskaeva
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
I. V. Romanova
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
L. K. Danilova
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
A. A. Evsyukov
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
O. V. Tutyrina
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
L. E. Tepnadze
Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Krasnoyarsk
T. I. Yakunchenko
Belgorod National Research University
Russian Federation
Russian Federation
Belgorod
O. V. Mevsha
Belgorod National Research University
Russian Federation
Russian Federation
Belgorod
Yu. A. Sharapova
Burdenko Voronezh State Medical University
Russian Federation
Russian Federation
Voronezh
T. M. Chernykh
Burdenko Voronezh State Medical University
Russian Federation
Russian Federation
Voronezh
E. V. Syomkina
AO Resort Belokurikha
Russian Federation
Russian Federation
Belokurikha
O. V. Tsygankova
Novosibirsk State Medical University;
Federal Research Center Institute of Cytology and Genetics
Russian Federation
Russian Federation
Novosibirsk
K. V. Protasov
Irkutsk State Medical Academy of Postgraduate Education — branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Irkutsk
O. V. Fedorishina
Irkutsk State Medical Academy of Postgraduate Education — branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Irkutsk
E. R. Makeeva
First-Called Apostle Andrew City Clinical Hospital;
Ulyanovsk State University
Russian Federation
Russian Federation
Ulyanovsk
Y. A. Smolkina
Ulyanovsk State University
Russian Federation
Russian Federation
Ulyanovsk
D. D. Nikishina
Ulyanovsk State University
Russian Federation
Russian Federation
Ulyanovsk
A. S. Verushkina
First-Called Apostle Andrew City Clinical Hospital
Russian Federation
Russian Federation
Ulyanovsk
E. A. Smirnova
I. P. Pavlov Ryazan State Medical University
Russian Federation
Russian Federation
Ryazan
Ya. A. Belenikina
I. P. Pavlov Ryazan State Medical University
Russian Federation
Russian Federation
Ryazan
I. V. Bikushova
I. P. Pavlov Ryazan State Medical University
Russian Federation
Russian Federation
Ryazan
M. V. Derevyanchenko
Volgograd State Medical University
Russian Federation
Russian Federation
Volgograd
V. V. Fedotov
Volgograd State Medical University
Russian Federation
Russian Federation
Volgograd
M. Yu. Shaposhnikova
Volgograd State Medical University
Russian Federation
Russian Federation
Volgograd
D. V. Sereda
City Clinic № 5
Russian Federation
Russian Federation
Volzhsky
E. A. Kartashova
Rostov State Medical University
Russian Federation
Russian Federation
Rostov-on-Don
E. I. Zheleznyak
Rostov State Medical University
Russian Federation
Russian Federation
Rostov-on-Don
D. M Rakhmatullina
Multidisciplinary Medical Center "DM Clinic"
Russian Federation
Russian Federation
Kazan
L. S. Kiseleva
Archbishop Luke City Clinical Hospital
Russian Federation
Russian Federation
Tambov
M. Evsevieva
Stavropol State Medical University
Russian Federation
Russian Federation
Stavropol
O. V. Sergeeva
Stavropol State Medical University
Russian Federation
Russian Federation
Stavropol
V. D. Kudryavtseva
Stavropol State Medical University
Russian Federation
Russian Federation
Stavropol
A. M. Zavyalova
Stavropol State Medical University
Russian Federation
Russian Federation
Stavropol
V. I. Slezova
Multidisciplinary Medical Center "Alpha Health Center"
Russian Federation
Russian Federation
Rostov-on-Don
K. T. Kitalaeva
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Astrakhan
N. N. Artemov
Almazov National Medical Research Center;
St. Petersburg National Research University of Information Technologies
Russian Federation
Russian Federation
St. Petersburg
A. A. Tanicheva
Almazov National Medical Research Center;
Russian Federation
Russian Federation
St. Petersburg
A. A. Konradi
Almazov National Medical Research Center;
Russian Federation
Russian Federation
St. Petersburg
E. V. Shlyakhto
Almazov National Medical Research Center;
Russian Federation
Russian Federation
St. Petersburg
References
1. Balanova YuA, Drapkina OM, Kutsenko VA, et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3785. (In Russ.). doi:10.15829/1728-8800-2023-3785.
2. Rotar OP, Erina AM, Boiarinova MA, et al. Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia. Russian Journal of Cardiology. 2022;27(4):5014. (In Russ.) doi:10.15829/1560-4071-2022-5014.
3. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;1-55. doi:10.1016/S0140-6736(24)00367-2.
4. Beaney T, Schutte AE, Stergiou GS, et al. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension. 2020;76(2):333-41. doi:10.1161/HYPERTENSIONAHA.120.14874.
5. Beaney T, Wang W, Schlaich MP, et al. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign. J Hypertens. 2023;41(9):1446-55. doi:10.1097/HJH.0000000000003488.
6. Gerdts E, Sudano I, Brouwers S, et al. Sex differences in arterial hypertension: A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy. European Heart Journal. 2022;43(46):4777-88. doi:10.1093/eurheartj/ehac470.
7. Balanova YuA, Shalnova SA, Kutsenko VA, et al. Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study. Rational Pharmacotherapy in Cardiology. 2024;20(1):4-12. (In Russ.). doi:10.20996/1819-6446-2024-3010.
8. Boytsov SA, Karpov YuA, Logunova NA, et al. Ways to increase adherence to antihypertensive therapy. Russian Journal of Cardiology. 2022;27(9):5202. (In Russ.) Бойцов С. А., Карпов Ю. А., Логунова Н. А. и др. Пути повышения приверженности к антигипертензивной терапии. Российский кардиологический журнал. 2022;27(9):5202.doi:10.15829/1560-4071-2022-5202.
9. Balanova JA, Shalnova SA, Kutsenko VA, et al. Population aspects of arterial hypertension therapy. Focus on fixed combinations. "Arterial'naya Gipertenziya" ("Arterial Hypertension"). 2022;28(5):482-91. (In Russ.). doi:10.18705/1607-419X-2022-28-5-482-491.
10. Venditti V, Bleve E, Morano S, Filardi T. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites. 2023;13(10):1087. doi:10.3390/metabo13101087.
11. Persell SD, Anthony L, Peprah YA, et al. Blood pressure outcomes at 18 months in primary care patients prescribed remote physiological monitoring for hypertension: a prospective cohort study. J Hum Hypertens. 2024;38(3):286-8. doi:10.1038/s41371-024-00904-7.
12. Drapkina ОM, Kotova MB, Maksimov SA, et al. Adherence to a healthy lifestyle in Russia according to the ESSE-RF study: is there a COVID-19 trace? Cardiovascular Therapy and Prevention. 2023;22(8S):3788. (In Russ.). doi:10.15829/1728-8800-2023-3788.
13. Drapkina OM, Maksimov SA, Shalnova SA, et al. Prevalence of smoking and its changes over time in Russia: data from the ESSE-RF study. Cardiovascular Therapy and Prevention. 2023;22(8S):3790. (In Russ.). doi:10.15829/1728-8800-2023-3790.
14. Tehrani H, Rajabi A, Ghelichi-Ghojogh M, et al. The prevalence of electronic cigarettes vaping globally: a systematic review and meta-analysis. Arch Public Health. 2022;80(240):1-15. doi:10.1186/s13690-022-00998-w.
15. Zhao J, Stockwell T, Naimi T, et al. Association Between Daily Alcohol Intake and Riskof All-Cause Mortality: A Systematic Review and Meta-analyses. JAMA Netw Open. 2023;6(3):1-17. doi:10.1001/jamanetworkopen.2023.6185.
16. Maksimov SA, Shalnova SA, Balanova YuA, et al. Alcohol consumption patterns in Russia according to the ESSE-RF study: is there a COVID-19 trace? Cardiovascular Therapy and Prevention. 2023;22(8S):3786. (In Russ.). doi:10.15829/1728-8800-2023-3786.
17. Ahmadi MN, Clare PJ, Katzmarzyk PT, et al. Vigorous physical activity, incident heart disease, and cancer: how little is enough? Eur Heart J. 2022;43(46):4801-14. doi:10.1093/eurheartj/ehac572.
18. Kotova MB, Maksimov SA, Shalnova SA, et al. Levels and types of physical activity in Russia according to the ESSE-RF study: is there a trace of the COVID-19 pandemic? Cardiovascular Therapy and Prevention. 2023;22(8S):3787. (In Russ.). doi:10.15829/1728-8800-2023-3787.
19. Balanova YuA, Drapkina OM, Kutsenko VA, et al. Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3793. (In Russ.). doi:10.15829/1728-8800-2023-3793.
20. Rotar OP, Tolkunova KM, Solntsev VN, et al. May Measurement Month 2019: adherence to treatment and hypertension control in Russia. Russian Journal of Cardiology. 2020;25(3):3745. (In Russ.). doi:10.15829/1560-4071-2020-3-3745.
21. Chazova IE, Zhernakova JuV, Oshhepkova EV, et al. Prevalence of cardiovascular diseases risk factors in Russian population of patients with arterial hypertension. Cardiologiia. 2014;54(10):4-12. (In Russ.). doi:10.18565/cardio.2014.10.
22. Dalal JJ, Padmanabhan TN, Jain P, et al. LIPITENSION: Interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab. 2012;16(2):240-5. doi:10.4103/2230-8210.93742.
23. Arif H, Aijaz B, Islam M, et al. Drug compliance after stroke and myocardial infarction: a comparative study. Neurol India. 2007;55(2):130-5. doi:10.4103/0028-3886.32783.
Supplementary files
Review
For citations:
Rotar O.P., Ilyanova I.N., Boyarinova M.A., Moguchaya E.V., Tolkunova K.M., Dyachkov V.A., Rubanenko O.A., Rubanenko A.O., Gaberman O.E., Gubareva E.Yu., Pomogaibo B.V., Dolya E.M., Kaliberdenko V.B., Avdeeva I.V., Tomashevskaya Yu.A., Falkovskaya A.Yu., Manukyan M.A., Solonskaya E.I., Vtorushina A.A., Khunkhinova S.A., Tsareva V.M., Molokoedova L.E., Petrova M.M., Kaskaeva D.S., Romanova I.V., Danilova L.K., Evsyukov A.A., Tutyrina O.V., Tepnadze L.E., Yakunchenko T.I., Mevsha O.V., Sharapova Yu.A., Chernykh T.M., Syomkina E.V., Tsygankova O.V., Protasov K.V., Fedorishina O.V., Makeeva E.R., Smolkina Y.A., Nikishina D.D., Verushkina A.S., Smirnova E.A., Belenikina Ya.A., Bikushova I.V., Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Sereda D.V., Kartashova E.A., Zheleznyak E.I., Rakhmatullina D.M., Kiseleva L.S., Evsevieva M., Sergeeva O.V., Kudryavtseva V.D., Zavyalova A.M., Slezova V.I., Kitalaeva K.T., Artemov N.N., Tanicheva A.A., Konradi A.A., Shlyakhto E.V. 2023 All-Russian screening for hypertension: results. Russian Journal of Cardiology. 2024;29(5):5931. (In Russ.) https://doi.org/10.15829/1560-4071-2024-5931. EDN: EMCJRB
Views:
3460
Email this article 